Role of Intraparotid and Neck Lymph Node Metastasis in Primary Parotid Cancer Surgery: A Population-Based Analysis

ORCID
0000-0002-4822-907X
Affiliation
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany;(M.K.);(B.K.)
Kouka, Mussab;
GND
132855151
Affiliation
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany;(M.K.);(B.K.)
Koehler, Benjamin;
GND
135983371
ORCID
0000-0001-7242-5727
Affiliation
Department of Otorhinolaryngology, Suedharzklinikum Nordhausen, 99734 Nordhausen, Germany;
Buentzel, Jens;
GND
113902123
Affiliation
Department of Otorhinolaryngology, Helios-Klinikum Erfurt, 99089 Erfurt, Germany;
Kaftan, Holger;
GND
122024060
Affiliation
Department of Otorhinolaryngology, SRH Zentralklinikum Suhl, 98527 Suhl, Germany;
Boeger, Daniel;
GND
128667281
ORCID
0000-0002-9820-5527
Affiliation
Department of Otorhinolaryngology, SRH Wald-Klinikum Gera, 07548 Gera, Germany;
Mueller, Andreas H.;
GND
141457325
Affiliation
Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07743 Jena, Germany;
Wittig, Andrea;
GND
172365473
Affiliation
Department of Oromaxillofacial Surgery and Plastic Surgery, Jena University Hospital, 07747 Jena, Germany;
Schultze-Mosgau, Stefan;
GND
1246219492
Affiliation
University Tumor Center, Jena University Hospital, 07747 Jena, Germany;
Ernst, Thomas;
GND
138812187
ORCID
0000-0001-7420-7707
Affiliation
Department of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital, 07743 Jena, Germany;
Schlattmann, Peter;
GND
1078441464
ORCID
0000-0001-9671-0784
Affiliation
Department of Otorhinolaryngology, Jena University Hospital, 07747 Jena, Germany;(M.K.);(B.K.)
Guntinas-Lichius, Orlando

Simple Summary The prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer is unclear. All 345 Thuringian patients with parotid cancer from 1996 to 2016 were included in a population-based study. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T became a strong prognosticator, but not LODDS. When combining T classification with LODDS-PAR, both higher T classification and the classification with LODDS-PAR became independent predictors of worse OS. LODDS-PAR seems to be an optimal prognosticator for OS in primary parotid cancer. Abstract This population-based study investigated the prognostic role of intraparotid (PAR) and cervical lymph node (LN) metastasis on overall survival (OS) of primary parotid cancer. All 345 patients (median age: 66 years; 43% female, 49% N+, 31% stage IV) of the Thuringian cancer registries with parotid cancer from 1996 to 2016 were included. OS was assessed in relation to the total number of removed PAR and cervical LN, number of positive intraparotid (PAR+), positive cervical LN, LN ratio, log odds of positive LN (LODDS), as well as including the PAR as LODDS-PAR. PAR was assessed in 42% of the patients (22% of these PAR+). T and N classification were not independent predictors of OS. When combining T with LODDS instead of N, higher T (T3/T4) became a prognosticator (hazard ratio (HR) = 2.588; CI = 1.329–5.040; p = 0.005) but not LODDS ( p > 0.05). When combining T classification with LODDS-PAR, both higher T classification (HR = 2.256; CI = 1.288–3.950; p = 0.004) and the alternative classification with LODDS-PAR (≥median −1.11; HR 2.078; CI = 1.155–3.739; p = 0.015) became independent predictors of worse OS. LODDS-PAR was the only independent prognosticator out of the LN assessment for primary parotid cancer.

Cite

Citation style:
Could not load citation form.

Rights

License Holder: © 2022 by the authors.

Use and reproduction:
This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.